Search research articles
Contact Us
Filters
Showing results (31-40 of 195) with videos related to
Page
of 20
Sort By:
Clinical Proteomics
|
October 4, 2013
Translation of proteomic biomarkers into FDA approved cancer diagnostics: issues and challenges
Anna K Füzéry, Joshua Levin, Maria M Chan, et al.
Clinical Chemistry
|
October 27, 2012
Integrated analyses of proteins and their glycans in a magnetic bead-based multiplex assay format
Danni Li, Hanching Chiu, Jing Chen, et al.
Clinical Chemistry
|
July 27, 2002
Proteomics and bioinformatics approaches for identification of serum biomarkers to detect breast cancer
Jinong Li, Zhen Zhang, Jason Rosenzweig, et al.
Clinical Proteomics
|
August 18, 2017
Protein signatures of molecular pathways in non-small cell lung carcinoma (NSCLC): comparison of glycoproteomics and global proteomics
Shuang Yang, Lijun Chen, Daniel W Chan, et al.
Proteomics. Clinical Applications
|
November 1, 2012
Glycoproteomics using fluid-based specimens in the discovery of lung cancer protein biomarkers: promise and challenge
Qing Kay Li, Ed Gabrielson, Frederic Askin, et al.
Clinical Proteomics
|
January 12, 2016
Advances in mass spectrometry-based clinical biomarker discovery
Christopher A Crutchfield, Stefani N Thomas, Lori J Sokoll, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 6, 2007
Annexin XI is associated with cisplatin resistance and related to tumor recurrence in ovarian cancer patients
Jin Song, Ie-ming Shih, Ritu Salani, et al.
Reviews in Urology
|
September 21, 2006
Modern Tumor Marker Discovery in Urology: Surface Enhanced Laser Desorption and Ionization (SELDI)
Matthew B Gretzer, Alan W Partin, Daniel W Chan, et al.
Journal of Proteome Research
|
November 28, 2008
Glycoproteomics for prostate cancer detection: changes in serum PSA glycosylation patterns
Danni L Meany, Zhen Zhang, Lori J Sokoll, et al.
Clinical Chemistry
|
October 12, 2011
Is the WHO 90:10 prostate-specific antigen (PSA) first international reference standard really 90% α1-antichymotrypsin-bound PSA and 10% free PSA?
Lori J Sokoll, Steven Rosenwald, Jeremy Lyons, et al.
Page
of 20
Search research articles
Search
Showing results (31-40 of 195) with videos related to
Sort By:
Page
of 20
Clinical Proteomics
|
October 4, 2013
Translation of proteomic biomarkers into FDA approved cancer diagnostics: issues and challenges
Anna K Füzéry, Joshua Levin, Maria M Chan, et al.
Clinical Chemistry
|
October 27, 2012
Integrated analyses of proteins and their glycans in a magnetic bead-based multiplex assay format
Danni Li, Hanching Chiu, Jing Chen, et al.
Clinical Chemistry
|
July 27, 2002
Proteomics and bioinformatics approaches for identification of serum biomarkers to detect breast cancer
Jinong Li, Zhen Zhang, Jason Rosenzweig, et al.
Clinical Proteomics
|
August 18, 2017
Protein signatures of molecular pathways in non-small cell lung carcinoma (NSCLC): comparison of glycoproteomics and global proteomics
Shuang Yang, Lijun Chen, Daniel W Chan, et al.
Proteomics. Clinical Applications
|
November 1, 2012
Glycoproteomics using fluid-based specimens in the discovery of lung cancer protein biomarkers: promise and challenge
Qing Kay Li, Ed Gabrielson, Frederic Askin, et al.
Clinical Proteomics
|
January 12, 2016
Advances in mass spectrometry-based clinical biomarker discovery
Christopher A Crutchfield, Stefani N Thomas, Lori J Sokoll, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 6, 2007
Annexin XI is associated with cisplatin resistance and related to tumor recurrence in ovarian cancer patients
Jin Song, Ie-ming Shih, Ritu Salani, et al.
Reviews in Urology
|
September 21, 2006
Modern Tumor Marker Discovery in Urology: Surface Enhanced Laser Desorption and Ionization (SELDI)
Matthew B Gretzer, Alan W Partin, Daniel W Chan, et al.
Journal of Proteome Research
|
November 28, 2008
Glycoproteomics for prostate cancer detection: changes in serum PSA glycosylation patterns
Danni L Meany, Zhen Zhang, Lori J Sokoll, et al.
Clinical Chemistry
|
October 12, 2011
Is the WHO 90:10 prostate-specific antigen (PSA) first international reference standard really 90% α1-antichymotrypsin-bound PSA and 10% free PSA?
Lori J Sokoll, Steven Rosenwald, Jeremy Lyons, et al.
Page
of 20